Registry of Pavia Chronic Heart Failure Patients-observational Study

December 5, 2025 updated by: Stefano Ghio, Fondazione IRCCS Policlinico San Matteo di Pavia
Registry of Pavia chronic heart failure patients-observational study

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

101

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pavia
      • Pavia, Pavia, Italy, 27100
        • Recruiting
        • Fondazione IRCCS Policlinico San Matteo di Pavia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

All ambulatory patients with HF in follow up at Fondazione IRCCS Policlinico San Matteo will be prospectively included in this study.

Description

Inclusion Criteria:

  • Give written informed consent to participate for the prospective evaluations
  • Suffer from CHF
  • Be aged 18 years and over

Exclusion Criteria:

  • Withdrawn of the consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
accurate and comprehensive data collection for all types of diseases that manifest themselves with heart failure in order to verify the "trajectory" of the disease
Time Frame: From enrollment to the end of treatment at visit 11 (9th years)
More specifically, mortality will be assessed one, five, and ten years after the initial diagnosis of heart failure.
From enrollment to the end of treatment at visit 11 (9th years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2022

Primary Completion (Actual)

December 31, 2024

Study Completion (Estimated)

November 1, 2031

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

December 5, 2025

First Posted (Actual)

December 18, 2025

Study Record Updates

Last Update Posted (Actual)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHF_22

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Subscribe